Section Arrow
CCEL.NYSE-M
- Cryo-Cell International
(Financial Status)
Quotes are at least 15-min delayed:2026/03/29 15:54 EDT
Regular Hours
Last
 3.31
+0.06 (+1.85%)
Day High 
3.39 
Prev. Close
3.25 
1-M High
3.42 
Volume 
38.00K 
Bid
1.57
Ask
3.53
Day Low
3.2 
Open
3.23 
1-M Low
2.72 
Market Cap 
26.18M 
Currency 美元 
P/E -- 
%Yield 4.53 
10-SMA 3.06 
20-SMA 3.15 
50-SMA 3.29 
52-W High 6.65 
52-W Low 2.72 
Exchange NYSE-M 
Valuation Estimation
EPS (Current/Estimated)
-0.30/--
Enterprise Value
34.82M
Balance Sheet
Book Value Per Share
-2.31
Cash Flow
Cash Flow Yield
0.21
Income Statement
Total Revenue
31.57M
Operating Revenue Per Share
3.88
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
AGLagilon health0.3962+0.0154+4.04%-- 
ACHCAcadia Healthcare Company22.91-0.94-3.94%19.82PE
BKDBrookdale Senior Living13.82+0.09+0.66%-- 
TOIOncology Institute (The)2.96-0.14-4.52%-- 
AIRSAirSculpt Technologies2.87-0.38-11.69%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.